APALUTAMIDE

APALUTAMIDE was reported 12037 times

APALUTAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IDIOPATHIC PANCREATITIS 4 0.1111
1 INTESTINAL TRANSIT TIME DECREASED 7 0.0909
2 CONCOMITANT DRUG EFFECT DECREASED 3 0.0698
3 HORMONE-DEPENDENT PROSTATE CANCER 4 0.0571
4 PROSTATIC SPECIFIC ANTIGEN DECREASED 14 0.0370
5 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 31 0.0299
6 PROSTATE CANCER METASTATIC 83 0.0248
7 HYPERSENSITIVITY MYOCARDITIS 3 0.0248
8 PROSTATIC SPECIFIC ANTIGEN INCREASED 314 0.0228
9 URETHRAL OBSTRUCTION 8 0.0198
10 GENITAL ATROPHY 3 0.0196
11 DERMATITIS EXFOLIATIVE GENERALISED 66 0.0190
12 AUTONOMIC DYSREFLEXIA 3 0.0185
13 METASTATIC BRONCHIAL CARCINOMA 3 0.0156
14 CYSTITIS RADIATION 3 0.0155
15 HEAT ILLNESS 10 0.0148
16 PRODUCT INFORMATION CONTENT COMPLAINT 4 0.0143
17 HORMONE-REFRACTORY PROSTATE CANCER 16 0.0135
18 INCORRECT DOSAGE ADMINISTERED 65 0.0133
19 EPIDERMOLYSIS BULLOSA 4 0.0129
20 OEDEMA GENITAL 8 0.0125
21 HOT FLUSH 922 0.0122
22 PROSTATECTOMY 7 0.0122
23 NEPHROSTOMY 4 0.0121
24 BLADDER MASS 6 0.0121
25 BLOOD TESTOSTERONE INCREASED 21 0.0098
26 LACUNAR STROKE 3 0.0094
27 PHYSICAL DECONDITIONING 24 0.0093
28 TESTICULAR ATROPHY 8 0.0092
29 GASTROENTERITIS RADIATION 3 0.0091
30 BLOOD TESTOSTERONE ABNORMAL 10 0.0090
31 ARRHYTHMIA SUPRAVENTRICULAR 9 0.0082
32 PROSTATE CANCER RECURRENT 5 0.0081
33 LICHENOID KERATOSIS 18 0.0079
34 MEASLES 4 0.0074
35 NEUROENDOCRINE CARCINOMA 5 0.0072
36 BLADDER CATHETERISATION 7 0.0072
37 THYROXINE FREE DECREASED 4 0.0071
38 ENANTHEMA 4 0.0069
39 URETHRAL HAEMORRHAGE 4 0.0066
40 CARDIAC PACEMAKER REPLACEMENT 3 0.0065
41 PENILE SIZE REDUCED 6 0.0063
42 RADIOTHERAPY 12 0.0063
43 HYPOTRICHOSIS 4 0.0062
44 HYPHAEMA 3 0.0057
45 BLOOD THYROID STIMULATING HORMONE INCREASED 50 0.0054
46 MARASMUS 8 0.0053
47 SKIN TOXICITY 29 0.0051
48 METASTASES TO PELVIS 3 0.0047
49 MILIARIA 8 0.0046
50 METASTASES TO BONE 74 0.0045
51 TESTICULAR PAIN 14 0.0044
52 DERMATITIS EXFOLIATIVE 22 0.0044
53 CUTANEOUS SYMPTOM 3 0.0044
54 METASTATIC NEOPLASM 18 0.0042
55 NASAL INJURY 3 0.0042
56 PROSTATIC OPERATION 5 0.0041
57 SPUTUM RETENTION 4 0.0040
58 DILATED CARDIOMYOPATHY 4 0.0040
59 MUSCLE ATROPHY 50 0.0039
60 PALLIATIVE CARE 6 0.0039
61 PRODUCT SIZE ISSUE 21 0.0039
62 THYROID HORMONES INCREASED 4 0.0038
63 SLEEP DEFICIT 8 0.0038
64 HOSPICE CARE 37 0.0037
65 CALCULUS BLADDER 5 0.0037
66 LISTLESS 12 0.0036
67 BLADDER TRANSITIONAL CELL CARCINOMA 5 0.0035
68 BREAST ENLARGEMENT 11 0.0034
69 EMERGENCY CARE 10 0.0033
70 BLOOD PHOSPHORUS DECREASED 12 0.0033
71 AGRANULOCYTOSIS 60 0.0032
72 NOCTURIA 39 0.0032
73 TASTE DISORDER 65 0.0032
74 TOXIC EPIDERMAL NECROLYSIS 48 0.0032
75 NON-CARDIAC CHEST PAIN 10 0.0032
76 THERAPY CESSATION 159 0.0031
77 CROSS SENSITIVITY REACTION 3 0.0031
78 RASH 1336 0.0031
79 EXFOLIATIVE RASH 8 0.0030
80 HIGH DENSITY LIPOPROTEIN INCREASED 3 0.0030
81 METASTASES TO SPINE 10 0.0030
82 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 76 0.0030
83 DRUG ERUPTION 52 0.0029
84 CAROTID ARTERIOSCLEROSIS 3 0.0029
85 HYPOTHYROIDISM 92 0.0029
86 RASH MACULO-PAPULAR 64 0.0029
87 URINARY BLADDER HAEMORRHAGE 6 0.0028
88 TERMINAL INSOMNIA 5 0.0028
89 METASTASES TO LYMPH NODES 19 0.0028
90 GENITAL RASH 4 0.0028
91 METASTASIS 20 0.0028
92 PRODUCT LABEL ISSUE 19 0.0028
93 SKIN EROSION 9 0.0028
94 ERECTILE DYSFUNCTION 71 0.0028
95 THERAPY CHANGE 27 0.0027
96 TEMPERATURE REGULATION DISORDER 6 0.0027
97 MENTAL FATIGUE 4 0.0027
98 REHABILITATION THERAPY 10 0.0026
99 DISCOURAGEMENT 6 0.0026
100 BLOOD TESTOSTERONE DECREASED 17 0.0025
101 LIPIDS INCREASED 5 0.0025
102 DERMATITIS PSORIASIFORM 5 0.0024
103 INJECTION RELATED REACTION 4 0.0024
104 MEDICAL PROCEDURE 4 0.0024
105 STEVENS-JOHNSON SYNDROME 53 0.0024
106 LAZINESS 4 0.0023
107 BLADDER NEOPLASM 4 0.0023
108 CERVICAL VERTEBRAL FRACTURE 8 0.0023
109 SPINAL CORD COMPRESSION 9 0.0023
110 DANDRUFF 5 0.0023
111 RESTLESS LEGS SYNDROME 40 0.0022
112 DENTAL CARE 4 0.0022
113 BLADDER SPASM 4 0.0021
114 PULMONARY TOXICITY 15 0.0021
115 INTERSTITIAL LUNG DISEASE 102 0.0021
116 URINE FLOW DECREASED 5 0.0021
117 OSTEOPOROTIC FRACTURE 4 0.0021
118 FAT TISSUE INCREASED 3 0.0021
119 RASH VESICULAR 10 0.0021
120 POLLAKIURIA 86 0.0021
121 FAECES HARD 8 0.0021
122 EAR HAEMORRHAGE 4 0.0020
123 PATHOLOGICAL FRACTURE 10 0.0020
124 HAEMORRHAGE URINARY TRACT 5 0.0020
125 CALCULUS URINARY 3 0.0019
126 CHANGE OF BOWEL HABIT 4 0.0019
127 BLOOD CHOLESTEROL ABNORMAL 9 0.0019
128 CEREBRAL ISCHAEMIA 10 0.0019
129 BONE LESION 7 0.0019
130 GASTROSTOMY 3 0.0019
131 GROIN PAIN 17 0.0019
132 NEOPLASM SKIN 3 0.0019
133 THERAPY INTERRUPTED 138 0.0019
134 DERMATITIS ALLERGIC 24 0.0019
135 HYPERPYREXIA 8 0.0019
136 TOXIC SKIN ERUPTION 19 0.0019
137 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
138 BONE CANCER 8 0.0018
139 BACTERIAL TEST POSITIVE 4 0.0018
140 DYSURIA 66 0.0018
141 ERYSIPELAS 9 0.0018
142 MYOCARDIAL NECROSIS MARKER INCREASED 3 0.0018
143 BRAIN FOG 28 0.0018
144 RASH PRURITIC 95 0.0018
145 APLASIA PURE RED CELL 6 0.0017
146 CHOREA 3 0.0017
147 URINARY RETENTION 58 0.0017
148 NIGHT SWEATS 56 0.0017
149 GASTROINTESTINAL NECROSIS 5 0.0017
150 AORTIC DISSECTION 7 0.0017
151 THYROID FUNCTION TEST ABNORMAL 7 0.0017
152 AORTIC VALVE STENOSIS 3 0.0017
153 LONG QT SYNDROME 4 0.0017
154 METABOLIC ENCEPHALOPATHY 5 0.0017
155 DYSCHEZIA 5 0.0016
156 SKIN REACTION 23 0.0016
157 RECTAL CANCER 5 0.0016
158 CATHETER PLACEMENT 3 0.0016
159 STENT PLACEMENT 13 0.0016
160 ERYTHEMA MULTIFORME 15 0.0016
161 EOSINOPHILIA 28 0.0016
162 HOSPITALISATION 245 0.0016
163 FATIGUE 1240 0.0016
164 FOREIGN BODY IN THROAT 5 0.0016
165 EOSINOPHILIC PNEUMONIA 5 0.0016
166 RETINAL ARTERY OCCLUSION 4 0.0016
167 ISCHAEMIC STROKE 28 0.0016
168 CANCER PAIN 4 0.0016
169 EXERCISE TOLERANCE DECREASED 9 0.0016
170 HEPATIC MASS 3 0.0016
171 CARCINOEMBRYONIC ANTIGEN INCREASED 3 0.0015
172 ORAL INFECTION 6 0.0015
173 URINE OUTPUT INCREASED 4 0.0015
174 HYPOGEUSIA 3 0.0015
175 PRODUCT DOSE OMISSION ISSUE 450 0.0015
176 HYPERTENSIVE CRISIS 17 0.0015
177 HAEMATURIA 52 0.0015
178 LUNG OPACITY 4 0.0015
179 BLADDER DISORDER 15 0.0015
180 SKIN PAPILLOMA 6 0.0015
181 THYROID DISORDER 23 0.0015
182 CARDIAC DISCOMFORT 3 0.0015
183 INTESTINAL RESECTION 8 0.0015
184 BLOOD SODIUM INCREASED 4 0.0015
185 SKIN ABRASION 7 0.0015
186 BLOOD POTASSIUM INCREASED 24 0.0015
187 NIPPLE PAIN 3 0.0015
188 TYPE IV HYPERSENSITIVITY REACTION 4 0.0015
189 AORTIC ANEURYSM 11 0.0014
190 LOSS OF LIBIDO 13 0.0014
191 MACULE 4 0.0014
192 TREATMENT NONCOMPLIANCE 78 0.0014
193 DECREASED APPETITE 330 0.0014
194 SKIN DISORDER 47 0.0014
195 DEATH 1203 0.0014
196 HEART VALVE INCOMPETENCE 4 0.0014
197 HEPATIC FUNCTION ABNORMAL 52 0.0014
198 BLOOD PRESSURE SYSTOLIC INCREASED 27 0.0014
199 DRUG INTERACTION 218 0.0014
200 IMMOBILE 6 0.0014
201 PHLEBITIS 7 0.0014
202 URINE ODOUR ABNORMAL 8 0.0014
203 AMYLASE INCREASED 5 0.0014
204 THORACIC VERTEBRAL FRACTURE 4 0.0014
205 CARDIAC DYSFUNCTION 5 0.0013
206 DIVERTICULUM INTESTINAL HAEMORRHAGIC 3 0.0013
207 CHEMOTHERAPY 5 0.0013
208 PROSTATITIS 4 0.0013
209 COMPRESSION FRACTURE 7 0.0013
210 PIGMENTATION DISORDER 8 0.0013
211 PROSTATE CANCER 104 0.0013
212 INCORRECT DOSE ADMINISTERED 295 0.0013
213 AGEUSIA 32 0.0013
214 ORAL SURGERY 3 0.0013
215 ADVERSE REACTION 17 0.0013
216 CARDIAC OPERATION 11 0.0013
217 NONSPECIFIC REACTION 7 0.0013
218 PROSTATOMEGALY 5 0.0013
219 CEREBRAL INFARCTION 31 0.0013
220 PULMONARY FIBROSIS 24 0.0012
221 URINARY INCONTINENCE 37 0.0012
222 INCONTINENCE 13 0.0012
223 HORMONE LEVEL ABNORMAL 6 0.0012
224 HAEMATOLOGICAL INFECTION 3 0.0012
225 MICTURITION URGENCY 14 0.0012
226 SUSPECTED COVID-19 4 0.0012
227 ORGANISING PNEUMONIA 6 0.0012
228 ANEURYSM 6 0.0012
229 ADVERSE DRUG REACTION 108 0.0012
230 GASTROINTESTINAL TUBE INSERTION 3 0.0012
231 FLUID INTAKE REDUCED 6 0.0012
232 PNEUMONIA BACTERIAL 11 0.0012
233 ADVERSE EVENT 110 0.0012
234 RASH ERYTHEMATOUS 57 0.0012
235 PRODUCT DISTRIBUTION ISSUE 11 0.0012
236 GENERAL PHYSICAL CONDITION ABNORMAL 8 0.0012
237 ASTHENIA 443 0.0012
238 HEPATIC CYTOLYSIS 15 0.0012
239 HYPERTHYROIDISM 17 0.0012
240 HYPERHIDROSIS 150 0.0012
241 INTERNATIONAL NORMALISED RATIO ABNORMAL 4 0.0012
242 ANURIA 10 0.0012
243 BONE PAIN 68 0.0012
244 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 9 0.0012
245 DISEASE PROGRESSION 137 0.0012
246 CATHETER SITE PAIN 3 0.0012
247 PELVIC PAIN 21 0.0012
248 FAILURE TO THRIVE 6 0.0012
249 MICTURITION DISORDER 4 0.0012
250 CHAPPED LIPS 5 0.0012
251 AORTIC STENOSIS 4 0.0011
252 ECZEMA 60 0.0011
253 DEMENTIA 32 0.0011
254 RASH MACULAR 40 0.0011
255 PRODUCT USE COMPLAINT 18 0.0011
256 POLYARTHRITIS 6 0.0011
257 NASAL DISORDER 3 0.0011
258 SKIN WEEPING 4 0.0011
259 QUALITY OF LIFE DECREASED 15 0.0011
260 BREAST SWELLING 3 0.0011
261 URINARY TRACT DISORDER 5 0.0011
262 DERMATITIS BULLOUS 8 0.0011
263 VASCULAR DEVICE INFECTION 5 0.0011
264 INCREASED APPETITE 21 0.0011
265 VENTRICULAR ARRHYTHMIA 4 0.0011
266 HYPERTENSION 231 0.0011
267 POLYNEUROPATHY 13 0.0011
268 ANGINA PECTORIS 31 0.0011
269 INITIAL INSOMNIA 11 0.0011
270 ENDOTRACHEAL INTUBATION 3 0.0011
271 HYDRONEPHROSIS 8 0.0011
272 BEDRIDDEN 14 0.0011
273 FALL 354 0.0011
274 BREAST TENDERNESS 8 0.0011
275 AUTOIMMUNE THYROIDITIS 4 0.0011
276 FRACTURE 20 0.0011
277 BLOOD URINE PRESENT 20 0.0011
278 BALANCE DISORDER 91 0.0011
279 BOWEL MOVEMENT IRREGULARITY 8 0.0010
280 CLAVICLE FRACTURE 4 0.0010
281 FIBULA FRACTURE 3 0.0010
282 MOUTH SWELLING 6 0.0010
283 METASTASES TO LUNG 12 0.0010
284 DYSPNOEA AT REST 3 0.0010
285 GYNAECOMASTIA 32 0.0010
286 OEDEMA PERIPHERAL 124 0.0010
287 HYPERTRANSAMINASAEMIA 7 0.0010
288 FEELING COLD 28 0.0010
289 ANAL INCONTINENCE 9 0.0010
290 DEFAECATION URGENCY 7 0.0010
291 TRIGEMINAL NEURALGIA 4 0.0010
292 INTERNATIONAL NORMALISED RATIO DECREASED 4 0.0010
293 PENILE PAIN 3 0.0010
294 DYSLIPIDAEMIA 5 0.0010
295 PERIPHERAL VENOUS DISEASE 4 0.0010
296 ANAPHYLACTOID REACTION 4 0.0010
297 METASTASES TO LIVER 17 0.0010
298 ACUTE CORONARY SYNDROME 8 0.0010
299 BLOOD CHOLESTEROL INCREASED 45 0.0010
300 EOSINOPHIL COUNT INCREASED 8 0.0010
301 CARDIAC FAILURE 77 0.0010
302 ONYCHOMADESIS 4 0.0010
303 IRIDOCYCLITIS 3 0.0009
304 EPILEPSY 29 0.0009
305 ATRIAL FIBRILLATION 92 0.0009
306 BUNDLE BRANCH BLOCK LEFT 4 0.0009
307 ABSCESS LIMB 4 0.0009
308 CARDIAC FAILURE CHRONIC 4 0.0009
309 HYPERCHOLESTEROLAEMIA 9 0.0009
310 BLOOD TEST ABNORMAL 13 0.0009
311 WEIGHT DECREASED 258 0.0009
312 URINE OUTPUT DECREASED 8 0.0009
313 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
314 DYSGEUSIA 67 0.0009
315 MOUTH ULCERATION 19 0.0009
316 CARDIOTOXICITY 8 0.0009
317 BLOOD PRESSURE INCREASED 137 0.0009
318 DYSPHAGIA 85 0.0009
319 ARTHRALGIA 371 0.0009
320 APATHY 13 0.0009
321 ELECTROCARDIOGRAM QT PROLONGED 32 0.0009
322 SKIN EXFOLIATION 75 0.0009
323 MUSCULAR WEAKNESS 101 0.0009
324 GRANULOCYTOPENIA 5 0.0009
325 SCAB 10 0.0009
326 PERIPHERAL COLDNESS 12 0.0009
327 LUMBAR VERTEBRAL FRACTURE 4 0.0009
328 SKIN ATROPHY 5 0.0009
329 EYE OPERATION 4 0.0009
330 GAIT INABILITY 29 0.0009
331 UROSEPSIS 8 0.0009
332 HAIR GROWTH ABNORMAL 6 0.0009
333 OEDEMA 47 0.0009
334 LOCALISED OEDEMA 4 0.0009
335 RENAL FUNCTION TEST ABNORMAL 4 0.0009
336 BLOOD PRESSURE ABNORMAL 17 0.0009
337 EMBOLIC STROKE 3 0.0009
338 NEUTROPENIA 115 0.0008
339 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
340 HYPOCALCAEMIA 16 0.0008
341 PLATELET COUNT INCREASED 11 0.0008
342 BODY HEIGHT DECREASED 9 0.0008
343 CARDIAC PACEMAKER INSERTION 5 0.0008
344 LIVER FUNCTION TEST INCREASED 18 0.0008
345 SEIZURE 96 0.0008
346 INGUINAL HERNIA 5 0.0008
347 VITAMIN D DECREASED 7 0.0008
348 SURGERY 48 0.0008
349 SENSORY DISTURBANCE 13 0.0008
350 NEOPLASM MALIGNANT 54 0.0008
351 URINARY TRACT INFECTION 138 0.0008
352 HEPATOTOXICITY 18 0.0008
353 SWELLING OF EYELID 5 0.0008
354 CORONARY ARTERY STENOSIS 4 0.0008
355 PRODUCT SOLUBILITY ABNORMAL 4 0.0008
356 LOSS OF CONTROL OF LEGS 3 0.0008
357 TROPONIN INCREASED 6 0.0008
358 PRODUCT COLOUR ISSUE 4 0.0008
359 PERIPHERAL VASCULAR DISORDER 4 0.0008
360 OROPHARYNGEAL DISCOMFORT 7 0.0008
361 SKIN NECROSIS 4 0.0008
362 CONSTIPATION 167 0.0008
363 PRURITUS 294 0.0008
364 COVID-19 PNEUMONIA 9 0.0008
365 LEUKOPENIA 38 0.0008
366 IDIOPATHIC PULMONARY FIBROSIS 3 0.0008
367 NERVE COMPRESSION 7 0.0008
368 BACK PAIN 176 0.0008
369 DRY SKIN 101 0.0008
370 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
371 SUDDEN DEATH 8 0.0008
372 DIZZINESS 376 0.0008
373 FEBRILE NEUTROPENIA 50 0.0008
374 CARDIAC FAILURE ACUTE 5 0.0007
375 SKIN MASS 5 0.0007
376 POOR QUALITY SLEEP 16 0.0007
377 FEMUR FRACTURE 23 0.0007
378 LEUKAEMIA 7 0.0007
379 PERIPHERAL SWELLING 114 0.0007
380 NEUTROPHIL COUNT DECREASED 30 0.0007
381 NEUROPATHY PERIPHERAL 70 0.0007
382 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
383 SKIN LACERATION 8 0.0007
384 FEELING HOT 45 0.0007
385 OESOPHAGITIS 8 0.0007
386 INFARCTION 5 0.0007
387 ASTHENOPIA 4 0.0007
388 GENERALISED OEDEMA 9 0.0007
389 SPINAL COMPRESSION FRACTURE 6 0.0007
390 ABNORMAL DREAMS 20 0.0007
391 LYMPHOEDEMA 5 0.0007
392 EMBOLISM 6 0.0007
393 HIP FRACTURE 23 0.0007
394 KIDNEY INFECTION 14 0.0007
395 INSOMNIA 190 0.0007
396 SKIN INFECTION 8 0.0007
397 ACUTE MYOCARDIAL INFARCTION 21 0.0007
398 FACE OEDEMA 12 0.0007
399 TRANSIENT ISCHAEMIC ATTACK 24 0.0007
400 INTESTINAL STENOSIS 3 0.0007
401 LIMB DISCOMFORT 22 0.0007
402 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
403 ANAEMIA 135 0.0007
404 FEBRILE BONE MARROW APLASIA 3 0.0007
405 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
406 EATING DISORDER 15 0.0007
407 MENTAL IMPAIRMENT 17 0.0007
408 MIDDLE INSOMNIA 13 0.0007
409 BLOOD MAGNESIUM DECREASED 6 0.0007
410 HEAD INJURY 22 0.0007
411 HEPATIC LESION 3 0.0007
412 BLOOD SODIUM DECREASED 13 0.0007
413 MENTAL DISORDER 30 0.0007
414 SLUGGISHNESS 7 0.0007
415 BLOOD CALCIUM INCREASED 6 0.0007
416 CARDIAC DISORDER 64 0.0007
417 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
418 EAR DISCOMFORT 7 0.0007
419 RIB FRACTURE 14 0.0007
420 CYTOMEGALOVIRUS INFECTION REACTIVATION 3 0.0007
421 DECREASED INTEREST 4 0.0007
422 BLINDNESS TRANSIENT 5 0.0007
423 ENERGY INCREASED 4 0.0007
424 SUNBURN 5 0.0007
425 HYPOPHAGIA 17 0.0007
426 HEPATITIS CHOLESTATIC 4 0.0007
427 HYPERSOMNIA 19 0.0007
428 PALLOR 18 0.0007
429 TENDON PAIN 5 0.0007
430 SYNCOPE 66 0.0007
431 ABDOMINAL HERNIA 3 0.0007
432 IMMUNE THROMBOCYTOPENIA 3 0.0007
433 ISCHAEMIA 3 0.0007
434 DIARRHOEA 421 0.0007
435 IRON DEFICIENCY ANAEMIA 6 0.0006
436 FEELING OF DESPAIR 3 0.0006
437 CEREBRAL HAEMORRHAGE 23 0.0006
438 PULMONARY THROMBOSIS 7 0.0006
439 PNEUMONIA ASPIRATION 16 0.0006
440 CELLULITIS 32 0.0006
441 ARRHYTHMIA 30 0.0006
442 SUBDURAL HAEMATOMA 9 0.0006
443 ERYTHEMA 129 0.0006
444 SCIATICA 10 0.0006
445 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
446 ATRIAL FLUTTER 5 0.0006
447 BLOOD PRESSURE FLUCTUATION 15 0.0006
448 HUMERUS FRACTURE 3 0.0006
449 PROCTALGIA 4 0.0006
450 COGNITIVE DISORDER 29 0.0006
451 CEREBROVASCULAR ACCIDENT 105 0.0006
452 DIZZINESS POSTURAL 6 0.0006
453 MUSCLE DISORDER 5 0.0006
454 BLOOD PRESSURE DECREASED 41 0.0006
455 THIRST 11 0.0006
456 HEPATITIS ACUTE 4 0.0006
457 AMNESIA 40 0.0006
458 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
459 DECUBITUS ULCER 5 0.0006
460 POLYP 4 0.0006
461 KNEE OPERATION 6 0.0006
462 MUCOUS STOOLS 3 0.0006
463 DRUG-INDUCED LIVER INJURY 19 0.0006
464 BLISTER 34 0.0006
465 RECTAL HAEMORRHAGE 26 0.0006
466 CORONAVIRUS INFECTION 4 0.0006
467 BLOOD ALKALINE PHOSPHATASE INCREASED 15 0.0006
468 COLON CANCER 9 0.0006
469 APPETITE DISORDER 4 0.0006
470 PRESCRIBED UNDERDOSE 12 0.0006
471 SECOND PRIMARY MALIGNANCY 5 0.0006
472 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
473 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
474 MALIGNANT MELANOMA 8 0.0006
475 CYSTITIS 19 0.0006
476 ENDOCARDITIS 3 0.0006
477 TRANSAMINASES INCREASED 13 0.0006
478 DYSPNOEA EXERTIONAL 22 0.0006
479 RENAL IMPAIRMENT 49 0.0006
480 CACHEXIA 3 0.0006
481 MYELOSUPPRESSION 21 0.0006
482 DYSSTASIA 17 0.0006
483 TEMPERATURE INTOLERANCE 6 0.0006
484 ONYCHOCLASIS 4 0.0006
485 WEIGHT INCREASED 130 0.0006
486 RASH PAPULAR 13 0.0006
487 EJECTION FRACTION DECREASED 9 0.0006
488 LARGE INTESTINE POLYP 4 0.0006
489 ADRENAL INSUFFICIENCY 7 0.0006
490 HYPERGLYCAEMIA 21 0.0006
491 SKIN SWELLING 5 0.0006
492 LABORATORY TEST ABNORMAL 17 0.0006
493 PAIN IN EXTREMITY 169 0.0006
494 DERMATITIS 12 0.0006
495 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
496 DEVICE OCCLUSION 8 0.0006
497 LYMPHOCYTE COUNT DECREASED 10 0.0006
498 SEASONAL ALLERGY 8 0.0006
499 MYALGIA 96 0.0006
500 BREAST PAIN 6 0.0006
501 TOOTH EXTRACTION 7 0.0006
502 MYOCARDIAL INFARCTION 98 0.0006
503 RED BLOOD CELL COUNT DECREASED 16 0.0006
504 OSTEOPOROSIS 23 0.0006
505 HYPOACUSIS 24 0.0006
506 LETHARGY 32 0.0006
507 GLYCOSYLATED HAEMOGLOBIN INCREASED 14 0.0006
508 CHEILITIS 3 0.0006
509 HIP SURGERY 3 0.0006
510 CARDIOVASCULAR DISORDER 14 0.0006
511 HYPOKINESIA 8 0.0006
512 LIP DRY 5 0.0005
513 FAECES SOFT 4 0.0005
514 BONE DISORDER 10 0.0005
515 ASPIRATION 6 0.0005
516 DYSPHONIA 32 0.0005
517 MOUTH HAEMORRHAGE 4 0.0005
518 DEAFNESS UNILATERAL 3 0.0005
519 WHITE BLOOD CELL COUNT DECREASED 59 0.0005
520 METASTASES TO CENTRAL NERVOUS SYSTEM 7 0.0005
521 DIVERTICULITIS 15 0.0005
522 LIVER DISORDER 24 0.0005
523 VENTRICULAR FIBRILLATION 6 0.0005
524 BODY TEMPERATURE INCREASED 11 0.0005
525 EPISTAXIS 40 0.0005
526 MOOD SWINGS 17 0.0005
527 MEMORY IMPAIRMENT 73 0.0005
528 TOOTH INFECTION 7 0.0005
529 PERIORBITAL SWELLING 3 0.0005
530 SARS-COV-2 TEST POSITIVE 7 0.0005
531 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
532 GAIT DISTURBANCE 101 0.0005
533 PRODUCT PACKAGING ISSUE 5 0.0005
534 INTENTIONAL DOSE OMISSION 15 0.0005
535 HAEMOGLOBIN DECREASED 54 0.0005
536 MUSCULOSKELETAL DISCOMFORT 9 0.0005
537 KNEE ARTHROPLASTY 11 0.0005
538 HIP ARTHROPLASTY 8 0.0005
539 CORONARY ARTERY BYPASS 3 0.0005
540 HERPES VIRUS INFECTION 3 0.0005
541 BLOOD URIC ACID INCREASED 3 0.0005
542 HERNIA 10 0.0005
543 MUSCULOSKELETAL CHEST PAIN 8 0.0005
544 ORTHOSTATIC HYPOTENSION 9 0.0005
545 ELECTROLYTE IMBALANCE 6 0.0005
546 HYPOAESTHESIA 77 0.0005
547 PELVIC FRACTURE 4 0.0005
548 COVID-19 90 0.0005
549 INFUSION RELATED REACTION 34 0.0005
550 HYPERTRIGLYCERIDAEMIA 3 0.0005
551 HAEMORRHAGIC STROKE 4 0.0005
552 SKIN FISSURES 10 0.0005
553 COLD SWEAT 9 0.0005
554 GENERAL PHYSICAL HEALTH DETERIORATION 59 0.0005
555 THROMBOSIS 41 0.0005
556 VERTIGO 31 0.0005
557 LYMPHADENOPATHY 18 0.0005
558 HEAD DISCOMFORT 9 0.0005
559 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
560 PNEUMONIA 164 0.0005
561 BLOOD IRON DECREASED 6 0.0005
562 BACTERAEMIA 6 0.0005
563 CHILLS 59 0.0005
564 MOBILITY DECREASED 36 0.0005
565 BLOOD DISORDER 4 0.0005
566 GANGRENE 3 0.0005
567 LYMPHOPENIA 7 0.0005
568 FLATULENCE 28 0.0005
569 BLOOD GLUCOSE INCREASED 93 0.0005
570 DERMATITIS ACNEIFORM 3 0.0005
571 DEPRESSED MOOD 26 0.0005
572 HAEMATOCHEZIA 27 0.0005
573 PHOTOSENSITIVITY REACTION 8 0.0005
574 FREQUENT BOWEL MOVEMENTS 13 0.0005
575 MALIGNANT NEOPLASM PROGRESSION 49 0.0005
576 HYPOKALAEMIA 22 0.0005
577 SCRATCH 5 0.0005
578 GASTRIC ULCER 9 0.0005
579 PYREXIA 162 0.0005
580 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
581 DECREASED ACTIVITY 5 0.0005
582 MUSCLE STRAIN 4 0.0005
583 LUNG NEOPLASM MALIGNANT 19 0.0005
584 STOMATITIS 28 0.0005
585 DEAFNESS 12 0.0005
586 MUSCULOSKELETAL PAIN 24 0.0005
587 INSURANCE ISSUE 7 0.0005
588 GASTROINTESTINAL DISORDER 41 0.0005
589 SKIN DISCOLOURATION 21 0.0005
590 PRODUCT COMMUNICATION ISSUE 4 0.0005
591 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
592 DYSARTHRIA 17 0.0005
593 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
594 EYE HAEMORRHAGE 6 0.0004
595 SPINAL FRACTURE 9 0.0004
596 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
597 ALOPECIA 88 0.0004
598 FULL BLOOD COUNT DECREASED 9 0.0004
599 SWELLING FACE 29 0.0004
600 BRONCHIECTASIS 3 0.0004
601 BLOOD CALCIUM DECREASED 5 0.0004
602 POSTOPERATIVE WOUND INFECTION 3 0.0004
603 PNEUMOTHORAX 7 0.0004
604 GASTROINTESTINAL CARCINOMA 4 0.0004
605 ABNORMAL LOSS OF WEIGHT 3 0.0004
606 MYOCARDIAL ISCHAEMIA 5 0.0004
607 DERMATITIS CONTACT 5 0.0004
608 HALLUCINATION 33 0.0004
609 CHOLECYSTECTOMY 5 0.0004
610 INTERNAL HAEMORRHAGE 5 0.0004
611 CORONARY ARTERY OCCLUSION 6 0.0004
612 LOSS OF CONSCIOUSNESS 56 0.0004
613 NEOPLASM 5 0.0004
614 GASTRIC CANCER 11 0.0004
615 MUSCLE TWITCHING 10 0.0004
616 NIGHTMARE 15 0.0004
617 LARGE INTESTINE PERFORATION 3 0.0004
618 WOUND 12 0.0004
619 CORONARY ARTERY DISEASE 13 0.0004
620 PAPULE 3 0.0004
621 ARTERIOSCLEROSIS 4 0.0004
622 SQUAMOUS CELL CARCINOMA 4 0.0004
623 DRUG INTOLERANCE 41 0.0004
624 HEART RATE INCREASED 42 0.0004
625 VENTRICULAR TACHYCARDIA 7 0.0004
626 SPINAL DISORDER 4 0.0004
627 SOMNOLENCE 85 0.0004
628 EMOTIONAL DISORDER 13 0.0004
629 ACCIDENT 5 0.0004
630 OFF LABEL USE 365 0.0004
631 CHEST PAIN 77 0.0004
632 GLAUCOMA 8 0.0004
633 MYELODYSPLASTIC SYNDROME 6 0.0004
634 PRODUCT DOSE OMISSION 27 0.0004
635 PRESYNCOPE 10 0.0004
636 PULMONARY EMBOLISM 39 0.0004
637 BODY TEMPERATURE DECREASED 4 0.0004
638 HYPOPHOSPHATAEMIA 3 0.0004
639 SPINAL OPERATION 5 0.0004
640 MALAISE 178 0.0004
641 LIMB INJURY 11 0.0004
642 HYPERCALCAEMIA 5 0.0004
643 FEELING DRUNK 3 0.0004
644 HAEMATOCRIT DECREASED 8 0.0004
645 PULMONARY MASS 6 0.0004
646 DYSPNOEA 227 0.0004
647 HYPOTONIA 4 0.0004
648 ABDOMINAL DISCOMFORT 67 0.0004
649 HEART RATE IRREGULAR 9 0.0004
650 PAROSMIA 3 0.0004
651 DEHYDRATION 53 0.0004
652 OSTEOPENIA 6 0.0004
653 NECK PAIN 22 0.0004
654 EYELID PTOSIS 4 0.0004
655 DISCOMFORT 24 0.0004
656 DRUG LEVEL DECREASED 4 0.0004
657 TOOTH ABSCESS 4 0.0004
658 NEUTROPHIL COUNT INCREASED 4 0.0004
659 GOUT 7 0.0004
660 PERICARDIAL EFFUSION 9 0.0004
661 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
662 ATRIOVENTRICULAR BLOCK 3 0.0004
663 GASTROENTERITIS VIRAL 7 0.0004
664 RASH GENERALISED 10 0.0004
665 VENTRICULAR EXTRASYSTOLES 4 0.0004
666 BASAL CELL CARCINOMA 6 0.0004
667 WEIGHT FLUCTUATION 4 0.0004
668 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
669 DISORIENTATION 15 0.0004
670 BLOOD ALBUMIN DECREASED 3 0.0004
671 LOCALISED INFECTION 9 0.0004
672 FEELING ABNORMAL 89 0.0004
673 CONFUSIONAL STATE 60 0.0004
674 TINNITUS 17 0.0004
675 COLITIS 14 0.0004
676 FAECES DISCOLOURED 8 0.0004
677 ILLNESS 38 0.0004
678 BACK INJURY 4 0.0004
679 ASPHYXIA 3 0.0004
680 PRODUCT PRESCRIBING ISSUE 8 0.0004
681 MOOD ALTERED 10 0.0004
682 LIVER INJURY 9 0.0004
683 POLYURIA 3 0.0004
684 CHOLELITHIASIS 12 0.0004
685 BLOOD GLUCOSE FLUCTUATION 4 0.0004
686 RENAL DISORDER 17 0.0004
687 ESCHERICHIA INFECTION 3 0.0004
688 SKIN LESION 10 0.0004
689 POST PROCEDURAL COMPLICATION 7 0.0004
690 APHASIA 11 0.0004
691 MELAENA 8 0.0004
692 DENTAL CARIES 4 0.0004
693 HYPERSENSITIVITY 67 0.0004
694 NERVE INJURY 4 0.0004
695 HAEMORRHOIDS 7 0.0004
696 SEPSIS 40 0.0004
697 BLOOD UREA INCREASED 6 0.0004
698 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
699 OCULAR DISCOMFORT 4 0.0004
700 ARTHRITIS 28 0.0004
701 HYPONATRAEMIA 20 0.0004
702 SLEEP DISORDER 25 0.0004
703 HEMIPARESIS 6 0.0004
704 FLUID RETENTION 18 0.0004
705 FACIAL PARALYSIS 3 0.0004
706 INJECTION SITE MASS 13 0.0004
707 UPPER LIMB FRACTURE 7 0.0004
708 SKIN ULCER 9 0.0003
709 HERPES ZOSTER 20 0.0003
710 PRODUCT ADMINISTRATION ERROR 7 0.0003
711 LIVER FUNCTION TEST ABNORMAL 10 0.0003
712 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
713 NAIL DISORDER 3 0.0003
714 GASTROENTERITIS 5 0.0003
715 ALANINE AMINOTRANSFERASE INCREASED 21 0.0003
716 HEART RATE DECREASED 12 0.0003
717 SPINAL PAIN 4 0.0003
718 SKIN HAEMORRHAGE 5 0.0003
719 PRODUCT PRESCRIBING ERROR 8 0.0003
720 VISION BLURRED 46 0.0003
721 MACULAR DEGENERATION 4 0.0003
722 JAUNDICE 9 0.0003
723 URTICARIA 56 0.0003
724 WRIST FRACTURE 4 0.0003
725 DRY MOUTH 27 0.0003
726 PAIN 204 0.0003
727 HALLUCINATION, VISUAL 7 0.0003
728 TOOTHACHE 6 0.0003
729 LIP SWELLING 11 0.0003
730 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
731 ACCIDENTAL OVERDOSE 12 0.0003
732 DIABETES MELLITUS 25 0.0003
733 NEPHROLITHIASIS 15 0.0003
734 INCREASED TENDENCY TO BRUISE 3 0.0003
735 ABDOMINAL DISTENSION 34 0.0003
736 INFECTION 47 0.0003
737 LYMPHOMA 5 0.0003
738 CONJUNCTIVITIS 6 0.0003
739 THROMBOCYTOPENIA 36 0.0003
740 MUSCLE SPASMS 59 0.0003
741 APPENDICITIS 3 0.0003
742 DELIRIUM 11 0.0003
743 DISTURBANCE IN ATTENTION 17 0.0003
744 NAUSEA 249 0.0003
745 EYE INFLAMMATION 3 0.0003
746 ORAL PAIN 7 0.0003
747 PLEURAL EFFUSION 19 0.0003
748 CARDIO-RESPIRATORY ARREST 13 0.0003
749 SWELLING 29 0.0003
750 NASOPHARYNGITIS 57 0.0003
751 MUSCLE TIGHTNESS 5 0.0003
752 PHARYNGEAL SWELLING 3 0.0003
753 NODULE 4 0.0003
754 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
755 JOINT STIFFNESS 8 0.0003
756 HYPOTENSION 61 0.0003
757 SINUS DISORDER 6 0.0003
758 C-REACTIVE PROTEIN INCREASED 11 0.0003
759 CATARACT 18 0.0003
760 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
761 RESTLESSNESS 11 0.0003
762 CARDIAC FAILURE CONGESTIVE 24 0.0003
763 VISUAL IMPAIRMENT 37 0.0003
764 EMPHYSEMA 3 0.0003
765 SINUS CONGESTION 4 0.0003
766 FEEDING DISORDER 6 0.0003
767 ANGER 10 0.0003
768 PARAESTHESIA 46 0.0003
769 PALPITATIONS 34 0.0003
770 EYE DISCHARGE 3 0.0003
771 NERVOUS SYSTEM DISORDER 9 0.0003
772 PETECHIAE 3 0.0003
773 PANCYTOPENIA 16 0.0003
774 DEPRESSION 65 0.0003
775 NEUROTOXICITY 5 0.0003
776 DYSPEPSIA 28 0.0003
777 JOINT DISLOCATION 3 0.0003
778 BRONCHITIS 21 0.0003
779 FULL BLOOD COUNT ABNORMAL 3 0.0003
780 CONTUSION 27 0.0003
781 PARALYSIS 4 0.0003
782 SKIN CANCER 6 0.0003
783 HAEMORRHAGE 29 0.0003
784 OSTEOMYELITIS 5 0.0003
785 GASTROINTESTINAL PAIN 3 0.0003
786 PRODUCTIVE COUGH 13 0.0003
787 ABDOMINAL PAIN UPPER 56 0.0003
788 ANGIOEDEMA 12 0.0003
789 MALNUTRITION 3 0.0003
790 PULMONARY OEDEMA 12 0.0003
791 HEADACHE 168 0.0003
792 PANCREATITIS ACUTE 6 0.0003
793 PHOTOPHOBIA 5 0.0003
794 CHROMATURIA 6 0.0003
795 EYE INFECTION 3 0.0003
796 HYPOAESTHESIA ORAL 4 0.0003
797 INTESTINAL OBSTRUCTION 10 0.0003
798 LUNG DISORDER 13 0.0003
799 PANCREATITIS 14 0.0003
800 RENAL FAILURE 35 0.0003
801 PLATELET COUNT DECREASED 28 0.0003
802 DEEP VEIN THROMBOSIS 17 0.0003
803 GASTRIC HAEMORRHAGE 3 0.0003
804 CHOLESTASIS 5 0.0003
805 BLOOD CREATININE INCREASED 17 0.0003
806 DEVICE RELATED INFECTION 4 0.0003
807 ERUCTATION 5 0.0003
808 PNEUMONITIS 7 0.0003
809 CHOKING 5 0.0003
810 CHOLECYSTITIS 3 0.0003
811 ULCER 4 0.0003
812 MUSCULOSKELETAL STIFFNESS 22 0.0003
813 HYPERLIPIDAEMIA 3 0.0003
814 DIABETIC KETOACIDOSIS 6 0.0002
815 HEPATIC ENZYME INCREASED 17 0.0002
816 HEPATITIS C 3 0.0002
817 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
818 PRODUCT PHYSICAL ISSUE 5 0.0002
819 BURSITIS 3 0.0002
820 NEURALGIA 6 0.0002
821 CYTOPENIA 3 0.0002
822 THERAPY NON-RESPONDER 11 0.0002
823 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 44 0.0002
824 MULTIPLE FRACTURES 4 0.0002
825 PHARYNGITIS 3 0.0002
826 ILEUS 3 0.0002
827 TYPE 2 DIABETES MELLITUS 8 0.0002
828 ABDOMINAL PAIN LOWER 6 0.0002
829 CANDIDA INFECTION 4 0.0002
830 ACUTE KIDNEY INJURY 36 0.0002
831 HEPATIC FAILURE 7 0.0002
832 RHINORRHOEA 15 0.0002
833 INJECTION SITE INDURATION 3 0.0002
834 MUCOSAL INFLAMMATION 6 0.0002
835 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
836 SYRINGE ISSUE 4 0.0002
837 HYPERKALAEMIA 8 0.0002
838 COUGH 63 0.0002
839 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
840 SHOCK 5 0.0002
841 BLOOD GLUCOSE ABNORMAL 4 0.0002
842 MENTAL STATUS CHANGES 6 0.0002
843 ORAL DISCOMFORT 3 0.0002
844 HUNGER 3 0.0002
845 CHEST DISCOMFORT 22 0.0002
846 MASS 3 0.0002
847 BACTERIAL INFECTION 4 0.0002
848 OXYGEN SATURATION DECREASED 12 0.0002
849 PAIN IN JAW 6 0.0002
850 DIALYSIS 3 0.0002
851 NERVOUSNESS 11 0.0002
852 LOWER LIMB FRACTURE 4 0.0002
853 PARAESTHESIA ORAL 3 0.0002
854 BRADYCARDIA 11 0.0002
855 ANOSMIA 3 0.0002
856 SEPTIC SHOCK 9 0.0002
857 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
858 INFLUENZA 23 0.0002
859 INTENTIONAL PRODUCT USE ISSUE 18 0.0002
860 ORAL HERPES 4 0.0002
861 CARDIOMYOPATHY 3 0.0002
862 OESOPHAGEAL CARCINOMA 6 0.0002
863 OSTEONECROSIS OF JAW 5 0.0002
864 IMMUNODEFICIENCY 3 0.0002
865 BONE LOSS 3 0.0002
866 IRRITABILITY 12 0.0002
867 BLOOD POTASSIUM DECREASED 6 0.0002
868 EXTRA DOSE ADMINISTERED 8 0.0002
869 CARDIAC ARREST 16 0.0002
870 UNRESPONSIVE TO STIMULI 5 0.0002
871 DRUG INEFFECTIVE 255 0.0002
872 HAEMATOMA 5 0.0002
873 TREMOR 32 0.0002
874 ACUTE MYELOID LEUKAEMIA 3 0.0002
875 SWOLLEN TONGUE 6 0.0002
876 RESPIRATORY TRACT INFECTION 5 0.0002
877 TACHYCARDIA 17 0.0002
878 GASTRITIS 5 0.0002
879 JOINT INJURY 4 0.0002
880 NASAL CONGESTION 11 0.0002
881 MOVEMENT DISORDER 6 0.0002
882 FEAR 5 0.0002
883 BACK DISORDER 3 0.0002
884 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
885 VOMITING 86 0.0002
886 IMPAIRED HEALING 6 0.0002
887 JOINT SWELLING 22 0.0002
888 COAGULOPATHY 3 0.0002
889 THROAT IRRITATION 8 0.0002
890 UNDERDOSE 13 0.0002
891 CIRCULATORY COLLAPSE 3 0.0002
892 LOWER RESPIRATORY TRACT INFECTION 8 0.0002
893 PRODUCT AVAILABILITY ISSUE 4 0.0002
894 SINUSITIS 18 0.0002
895 GASTRIC DISORDER 6 0.0002
896 SUICIDAL IDEATION 16 0.0002
897 INFLAMMATION 9 0.0002
898 PANCREATIC CARCINOMA 5 0.0002
899 NEOPLASM PROGRESSION 6 0.0002
900 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
901 ANXIETY 49 0.0002
902 UNEVALUABLE EVENT 13 0.0002
903 SPEECH DISORDER 9 0.0002
904 BURNING SENSATION 12 0.0002
905 PRODUCT USE ISSUE 32 0.0002
906 PSYCHOTIC DISORDER 5 0.0002
907 GALLBLADDER DISORDER 3 0.0002
908 FLUSHING 17 0.0002
909 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
910 HYPOGLYCAEMIA 8 0.0002
911 MEDICATION ERROR 9 0.0002
912 DRY EYE 8 0.0002
913 AGGRESSION 8 0.0002
914 HEPATIC CIRRHOSIS 3 0.0002
915 BONE DENSITY DECREASED 5 0.0002
916 EYE PAIN 9 0.0002
917 METABOLIC ACIDOSIS 5 0.0002
918 ACUTE RESPIRATORY FAILURE 3 0.0002
919 ANAPHYLACTIC SHOCK 4 0.0002
920 EAR PAIN 3 0.0002
921 DIPLOPIA 4 0.0002
922 DISABILITY 3 0.0002
923 CYTOKINE RELEASE SYNDROME 3 0.0001
924 PAIN OF SKIN 4 0.0001
925 THERAPEUTIC RESPONSE DECREASED 9 0.0001
926 BONE MARROW FAILURE 3 0.0001
927 BLINDNESS 6 0.0001
928 INJECTION SITE PAIN 45 0.0001
929 ABDOMINAL PAIN 34 0.0001
930 INFLUENZA LIKE ILLNESS 12 0.0001
931 ANAPHYLACTIC REACTION 8 0.0001
932 ARTHROPATHY 8 0.0001
933 ROAD TRAFFIC ACCIDENT 6 0.0001
934 OSTEOARTHRITIS 6 0.0001
935 CONDITION AGGRAVATED 43 0.0001
936 IMPAIRED WORK ABILITY 3 0.0001
937 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
938 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
939 PANIC ATTACK 5 0.0001
940 RESPIRATORY FAILURE 10 0.0001
941 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
942 SKIN IRRITATION 6 0.0001
943 OCULAR HYPERAEMIA 6 0.0001
944 PRODUCT STORAGE ERROR 11 0.0001
945 INJECTION SITE HAEMORRHAGE 10 0.0001
946 BLOOD GLUCOSE DECREASED 6 0.0001
947 HEPATIC CANCER 3 0.0001
948 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 25 0.0001
949 EXPIRED PRODUCT ADMINISTERED 4 0.0001
950 VIRAL INFECTION 4 0.0001
951 RHABDOMYOLYSIS 5 0.0001
952 HAEMATEMESIS 3 0.0001
953 WHEEZING 7 0.0001
954 HEPATITIS 3 0.0001
955 PRODUCT USE IN UNAPPROVED INDICATION 29 0.0001
956 MIGRAINE 11 0.0001
957 INJURY 8 0.0001
958 EAR INFECTION 3 0.0001
959 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
960 BLOOD BILIRUBIN INCREASED 3 0.0001
961 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
962 OROPHARYNGEAL PAIN 10 0.0001
963 EYE SWELLING 4 0.0001
964 TOXICITY TO VARIOUS AGENTS 18 0.0001
965 ACNE 8 0.0001
966 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
967 PLASMA CELL MYELOMA 4 0.0001
968 LACRIMATION INCREASED 3 0.0001
969 PSORIASIS 12 0.0001
970 INJECTION SITE SWELLING 7 0.0001
971 FUNGAL INFECTION 3 0.0001
972 COLITIS ULCERATIVE 4 0.0001
973 EYE PRURITUS 3 0.0001
974 OVERDOSE 19 0.0001
975 COMA 4 0.0001
976 RENAL CANCER 4 0.0001
977 ABNORMAL BEHAVIOUR 3 0.0001
978 DYSKINESIA 3 0.0001
979 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
980 EYE IRRITATION 4 0.0001
981 AGITATION 5 0.0001
982 BLADDER CANCER 4 0.0001
983 ILL-DEFINED DISORDER 4 0.0001
984 TREATMENT FAILURE 5 0.0001
985 INJECTION SITE REACTION 4 0.0001
986 SKIN BURNING SENSATION 4 0.0001
987 ASTHMA 6 0.0001
988 EMOTIONAL DISTRESS 5 0.0000
989 DRUG WITHDRAWAL SYNDROME 3 0.0000
990 INJECTION SITE ERYTHEMA 3 0.0000
991 NO ADVERSE EVENT 3 0.0000